1. Home
  2. Epicentre
  3. team
  4. Issaka Soumana
Back to the list
Photo
Issaka soumana

Issaka Soumana

Titre du poste
Medical doctor and deputy director of Epicentre's research center, Maradi, Niger
Epicentre Niger
0000-0002-7268-4005
Contact by mail
Corps éditorial

Biography

Dr Issaka SOUMANA is a medical doctor with training in public health/global health from the Catholic University of Louvain. Currently deputy head of the Epicentre Research Centre in Maradi, he has worked on major vaccine trial projects as a field investigator in Niger and the DRC, in particular on the phase III clinical trial of a rotavirus vaccine in Niger, then on an Ebola vaccine in the DRC, and then on a pneumococcal vaccine used in fractional doses in mass vaccination campaigns. Dr Issaka has also taken part in field studies on antimalarial drugs and treatments for Ebola.

Evaluation of multiple micronutrient supplementation and medium-quantity lipid-based nutrient supplementation in pregnancy on child development in rural Niger: A secondary analysis of a cluster randomized controlled trial.

Journal Reference: PLoS medicine 2022 May ; 19(5); . doi: 10.1371/journal.pmed.1003984. Epub 2022 05 02

Prenatal supplementation with multiple micronutrient supplements or medium-quantity lipid-based nutrient supplements has limited effects on child growth up to 24 months in rural Niger: a secondary analysis of a cluster randomized trial.

Journal Reference: The American journal of clinical nutrition 2021 Dec 06; . doi: 10.1093/ajcn/nqab404. Epub 2021 12 06

Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.

Journal Reference: PLoS medicine 2021 Jul ; 18(7); e1003655. doi: 10.1371/journal.pmed.1003655. Epub 2021 07 02

Exploring the relationships in prenatal weight gain, birth outcomes, and postnatal growth up to 2 Years of age using a longitudinal cohort in Niger.

Journal Reference: Current Developments in Nutrition; Volume 4, Issue Supplement_2, June 2020; Page 1021, https://doi.org/10.1093/cdn/nzaa054_093

Safety of a heat-stable rotavirus vaccine among children in Niger: Data from a phase 3, randomized, double-blind, placebo-controlled trial.

Journal Reference: Vaccine 2018 06 14; 36(25); 3674-3680. doi: 10.1016/j.vaccine.2018.05.023. Epub 2018 05 08
See all